PIA
MRNA icon

Piedmont Investment Advisors’s Moderna MRNA Stock Holding History

Piedmont Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,888
Closed -$536K – 444
2020
Q1 		$536K Buy
17,888
+3,822
+27% +$87.9K 0.02% 428
2019
Q4 		$275K Buy
14,066
+567
+4% +$10.1K 0.01% 790
2019
Q3 		$215K Buy
+13,499
New +$199K 0.01% 857

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Piedmont Investment Advisors's MRNA Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Moderna (MRNA) in Q2 2020, closing a stake of 17,888 shares — an estimated $536K sold.

Piedmont Investment Advisors first reported a position in MRNA in Q3 2019 and held it in 3 quarters. The position peaked at $536K in Q1 2020. 490 funds tracked by Wall St. Rank hold MRNA as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Moderna position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 17,888 Moderna shares in Q2 2020, an estimated $536K.
  • Piedmont Investment Advisors first reported a position in Moderna in Q3 2019 and held it in 3 quarters.
  • Piedmont Investment Advisors's Moderna position peaked at $536K in Q1 2020.
  • 490 funds tracked by Wall St. Rank held Moderna as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.